Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Plus Therapeutics Inc PSTV

Healthcare Biotechnology
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers. The Company combines image-guided local beta radiation and targeted drug delivery approaches. The Company is advancing a pipeline of product candidates with lead programs in recurrent glioblastoma... see more

Bullboard (NDAQ:PSTV)

View:
Post by whytestockson Jul 13, 2023 8:15pm

Plus Therapeutics to Present at the 2nd Annual Targeted Radi

Just In: $PSTV Plus Therapeutics to Present at the 2nd Annual Targeted Radiopharmaceuticals SummitAUSTIN, Texas, July 13, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the & ...more  
42
Post by whytestockson Jun 14, 2023 9:00pm

Plus Therapeutics to Participate in the 2023 Healthcare Virt

BREAKING NEWS: $PSTV Plus Therapeutics to Participate in the 2023 Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-VestAUSTIN, Texas, June 14, 2023 (GLOBE NEWSWIRE) -- Plus ...more  
46
Post by Chester55on Aug 21, 2021 9:46am

I guess there is t anyone talking about this stock

Crickets.  Well I like this stock!!  Join me!!
129
Post by coolfooldumbguyon Dec 16, 2019 8:38pm

still holding this stock

used dollar cost averaging for it after getting caught by an upswing followed by a cheap stock financing,so glta shareholders but it could take time for an upswing here.
149
Post by coolfooldumbguyon Sep 25, 2019 2:51pm

it's a buy today for me

my last batch at these low prices,so glta shareholders.
158
Post by coolfooldumbguyon Sep 24, 2019 10:30am

still holding this stock

adding more shares this morning after the cheap financing yesterday collapsed the stock price, using dollar cost averaging on this one,so glta shareholders.
146
Post by coolfooldumbguyon Sep 23, 2019 2:21pm

the bottom is past for

people playing with it all day but its value is $16 per share,so glta shareholders.
164
Post by coolfooldumbguyon Sep 23, 2019 2:18pm

still holding this stock

this stock is way oversold,so glta shareholders.
128
Post by coolfooldumbguyon Sep 23, 2019 2:10pm

it's a buy today for me using DCA

by dollar cost averaging,and by loading up big time with this one,my target price for it is $16 per share,and my costs are $5.00 per share,and still waiting for more beaten down cheap shares.
113
Post by coolfooldumbguyon Sep 23, 2019 10:53am

it's a buy today for me

at $11.15 cents per share,so glta.
94
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities